Literature DB >> 10419653

Interleukin 5 release into asthmatic airways 4 and 24 hours after endobronchial allergen challenge: its relationship with eosinophil recruitment.

L M Teran1, M P Carroll, J K Shute, S T Holgate.   

Abstract

Interleukin 5 (IL-5), a cytokine with a range of activities on eosinophils, has been implicated in the allergic asthmatic reaction. We have investigated the kinetics of release of this cytokine into asthmatic airways as well as its relationship to eosinophil recruitment following allergen challenge. Twelve asthmatic patients underwent endobronchial allergen challenge and bronchoalveolar lavage (BAL) fluid was obtained either 4 h (n=6) or 24 h (n=6) after challenge. Four hours after challenge, levels of IL-5 were significantly increased in BAL fluid (10-fold concentration obtained from the allergen-challenge site compared with the saline control (median 2.67 pg/ml, range 1.0-7.4 pg/ml vs 1.0 pg/ml <1.0-2.4 pg/ml, P<0.05). At 24 h levels of IL-5 increased further at the allergen site but not at the saline control lavage (31.1 pg/ml, range 3.6-59. 0 pg/ml vs 1.5 pg/ml, range <1.5-4.9 pg/ml, respectively P<0.02). At 4h there was almost a three fold increase in IL-5 level, whereas at 24 h IL-5 levels were 20-fold greater. Differential cell counts showed that eosinophil numbers obtained 4 and 24 h after allergen challenge were 7 and 32 times higher than numbers after saline challenge. The parallel increase of eosinophil numbers and IL-5 concentrations in BAL fluid suggests that this cytokine may contribute to the eosinophil recruitment observed into asthmatic airways after allergen challenge. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419653     DOI: 10.1006/cyto.1998.0457

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

Review 1.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

Review 2.  Airway smooth muscle in the pathophysiology and treatment of asthma.

Authors:  Diana C Doeing; Julian Solway
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

Review 3.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

4.  Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model.

Authors:  David K Meyerholz; Michelle A Griffin; Elaine M Castilow; Steven M Varga
Journal:  Toxicol Pathol       Date:  2009-01-29       Impact factor: 1.902

5.  Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3.

Authors:  Konrad Pazdrak; Young Moon; Christof Straub; Susan Stafford; Alexander Kurosky
Journal:  Apoptosis       Date:  2016-04       Impact factor: 4.677

6.  Pro-inflammatory cytokines induce c-fos expression followed by IL-6 release in human airway smooth muscle cells.

Authors:  S McKay; M M Bromhaar; J C de Jongste; H C Hoogsteden; P R Saxena; H S Sharma
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

Review 7.  Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle.

Authors:  Sue McKay; Hari S Sharma
Journal:  Respir Res       Date:  2001-11-28

8.  Integrin activation States and eosinophil recruitment in asthma.

Authors:  Mats W Johansson; Deane F Mosher
Journal:  Front Pharmacol       Date:  2013-04-01       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.